Modulation of angiotensin II coronary vasoconstriction by cardiac prostaglandin synthesis.
D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D004285:Dogs; D006439:Hemodynamics / Q000187:drug effects*; D007213:Indomethacin / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D011448:Prostaglandin Antagonists; D011453:Prostaglandins / Q000096:biosynthesis*; D012039:Regional Blood Flow / Q000187:drug effects
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D000804:Angiotensin II; D007213:Indomethacin